HMGA1 variant IVS5-13insC is associated with insulin resistance and type 2 diabetes: an updated meta-analysis

Afr Health Sci. 2018 Dec;18(4):865-872. doi: 10.4314/ahs.v18i4.4.

Abstract

Background: High-mobility group A1 (HMGA1) polymorphism has been suspected as a gene variant associated with type 2 diabetes (T2D). However, conflicting outcomes have been reported.

Objective: This meta-analysis aimed to predict the association between the HMGA1 variant IVS5-13insC and T2D.

Methods: Statistical analyses were performed using Stata/SE 12.0 software.

Results: A total of 11 case-control studies in 6 articles were included. Results suggested that the HMGA1 variant IVS5-13insC was associated with an increased risk of insulin resistance (OR = 0.61, 95% CI 0.56 to 0.66, P < 0.0001), T2D (OR = 0.67, 95% CI 0.61 to 0.73, P < 0.0001), particularly for Caucasians with increased risks of T2D (OR = 0.56, 95% CI 0.49 to 0.65, P < 0.0001) compared with wild-type subjects.

Conclusion: This meta-analysis indicated that the HMGA1 variant IVS5-13insC can be a risk factor of T2D development, particularly among Caucasians. Significant risks were also found (Asian: OR = 0.74, 95% CI: 0.63 to 0.86, P < 0.0001, Hispanic-American: OR = 0.81, 95% CI: 0.65 to 1.01, P < 0.0001) in non-Caucasian population. However, ethnical studies should be conducted to reveal whether the HMGA1 variant IVS5-13insC is associated with an increased risk of T2D.

Keywords: HMGA1; insulin resistance; meta-analysis; type 2 diabetes; variant.

Publication types

  • Meta-Analysis

MeSH terms

  • Case-Control Studies
  • Diabetes Mellitus, Type 2 / ethnology
  • Diabetes Mellitus, Type 2 / genetics*
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • HMGA1a Protein / genetics*
  • Humans
  • Insulin Resistance / genetics*
  • Male
  • Odds Ratio
  • Polymorphism, Single Nucleotide
  • Racial Groups
  • Risk Factors

Substances

  • HMGA1a Protein